RxDoctor Payments Data

James Sikora, MD

Clinical Pathology · Atlanta, GANPI 1679899884

Payments from drug & device makers

$64,080in general payments, 2019–2025

Across 94 payments — averaging $681.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CSL Plasma Inc.$62K
  • Gilead$2K
  • Cerus Corporation$227

What the payments were for

  • Consulting fees$63,73099%
  • Food & beverage$3501%

General payments by program year

23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
CSL Plasma Inc.91$62,250
Gilead2$1,602
Cerus Corporation1$227

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few clinical pathology providers in Georgiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$2,314
Medicare patients
94
Services billed
124

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other clinical pathology in Atlanta

Where these figures come from

Is this you, or does something look wrong? →